<DOC>
	<DOCNO>NCT02301650</DOCNO>
	<brief_summary>Mother child transmission ( MTCT ) main route hepatitis B virus ( HBV ) transmission.High HBV DNA level pregnant woman main risk factor MTCT . Many literature demonstrate use nucleoside ( acid ) analog late pregnancy significantly reduce HBV DNA level effectively block MTCT . Therefore , treatment guideline hepatitis B Europe Asia Pacific region clearly point : Nucleoside ( acid ) analog use pregnant woman 28 week gestation block MTCT mother high HBV DNA level . At present , drug use late pregnancy include lamivudine ( LAM ) , telbivudine ( LdT ) tenofovir ( TDF ) . The safety nucleoside ( acid ) analogue use late pregnancy child clear.In related research , observation termination 7-12 month birth , concentrate block effect MTCT.The long-term impact Nucleoside ( acid ) analogues child 's development report literature . The aim study make clear effect nucleoside ( acid ) analogue use late pregnancy long-term impact child 's development . The one year old child bear Beijing Ditan hospital whose mother take LAM , LdT TDF late pregnancy enrol study group , eligible child whose mother untreated enrolled control group . The child 's height , weight , nutritional status , developmental quotient immune response hepatitis B vaccine etc evaluate baseline 3 year old . By compare child 's development different group well self-control different age , discuss effect Nucleoside ( acid ) analogues child 's long-term development .</brief_summary>
	<brief_title>The Effect Anti-viral Drugs Used Late Pregnancy Long-term Development Children</brief_title>
	<detailed_description />
	<mesh_term>Telbivudine</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>The one year old child whose mother take Lamivudine , Telbivudine Tenofovir late pregnancy ( 2830 week gestation ) ; The one year old child whose mother untreated late pregnancy ; Children complete standard hepatitis B vaccine hepatitis B immune globulin combine active passive prophylaxis ; HBV DNA level child 's mother 6.0 log10 IU/ml 28 week gestation . Children whose mother 35 year old delivery ; The couple family hereditary disease abnormal malformation find fetal screen 28 week gestation ; History amniocentesis pregnancy ; Coinfection either hepatitis C virus , hepatitis D virus , human immunodeficiency virus , syphilis , toxoplasmosis , rubella cytomegalovirus . Complications pregnancyinduced hypertension , premature rupture membrane , preterm birth , placenta previa placental abruption ; asphyxia birth .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Hepatitis B virus</keyword>
	<keyword>pregnancy</keyword>
	<keyword>nucleoside ( acid ) analog</keyword>
	<keyword>child</keyword>
	<keyword>safety</keyword>
</DOC>